Logo Logo Logo
  • Home
  • About Us
    • Strategic Plan
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
Logo Logo Logo Logo Logo Logo
  • Home
  • About Us
    • Strategic Plan
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
 

June 2017

Link icon

30 Jun Should Patients Continue to Receive Statins Once They Reach 80 Years of Age?

Posted at 22:56h in Blog 0 Comments
Share

Read more...

Read More

04 Jun This Changed My Practice: Seeking collateral information when clinical practice guidelines deliver strong recommendations for drug therapies on the basis of a single clinical trial

Posted at 09:20h in Education 0 Comments
Share

Cait O’Sullivan used to be too easily persuaded about the benefits and harms of a drug therapy on the basis of single randomized controlled trial. With little practice, she learned that Cochrane review summaries and FDA...

Read More

adverse effects adverse events antibacterial agents antidepressive agents artificial intelligence bias biosimilars chronic pain COPD covid-19 deprescribing Deprescriptions Diabetes Diabetes Mellitus Drug-Related Side Effects and Adverse Reactions Drug Costs drug safety gabapentin Glycemic Control guidelines hypertension inappropriate prescribing information dissemination machine learning meta-analysis methods opioid analgesics opioids overdiagnosis pain pharmacoepidemiology portrait pregabalin prescribing proton pump inhibitors publishing safety Sodium-Glucose Transporter 2 Inhibitors statistics substance withdrawal syndrome systematic review systematic reviews tofacitinib tramadol type 2 diabetes

Therapeutics Initiative logo

Our mission is to provide physicians, nurse practitioners, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. More about us

The Therapeutics Initiative is part of the Department of Anesthesiology, Pharmacology & Therapeutics at UBC's Faculty of Medicine.

Donate

 

Contact

Therapeutics Initiative
Dept of Anesthesiology, Pharmacology & Therapeutics
Faculty of Medicine
University of British Columbia

300 - 2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3

210 - 1110 Government Street
Victoria, BC, Canada V8W 1Y2

Office: +1 604-822-0700
Send us a message

 

Subscribe for Updates

Want to stay abreast of new therapeutics information? Then subscribe to receive email notices of upcoming Therapeutics Letters, educational events, and other announcements. We promise not to spam you and you won’t hear from us more than a few times a month.

Subscribe

Located on the traditional, ancestral and unceded territory of the hən̓q̓əmin̓əm̓ speaking peoples, including the xʷməθkwəy̓əm (Musqueam), the Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh), and the Skwxwú7mesh (Squamish) Nations, and on the lək̓ʷəŋən (Lekwungen) territory of the Songhees, Esquimalt and W̱SÁNEĆ peoples.

 
© Copyright 1994 - 2026 Therapeutics Initiative | Terms & Policies